Potent activity of the HIV-1 maturation inhibitor bevirimat in SCID-hu Thy/Liv mice.
<h4>Background</h4>The HIV-1 maturation inhibitor, 3-O-(3',3'-dimethylsuccinyl) betulinic acid (bevirimat, PA-457) is a promising drug candidate with 10 nM in vitro antiviral activity against multiple wild-type (WT) and drug-resistant HIV-1 isolates. Bevirimat has a novel mecha...
Saved in:
| Main Authors: | Cheryl A Stoddart, Pheroze Joshi, Barbara Sloan, Jennifer C Bare, Philip C Smith, Graham P Allaway, Carl T Wild, David E Martin |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2007-11-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0001251&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Validation of the SCID-hu Thy/Liv mouse model with four classes of licensed antiretrovirals.
by: Cheryl A Stoddart, et al.
Published: (2007-08-01) -
Altered mesenchymal and endothelial subsets in interstitial bone marrow and focal lesions in myeloma patients and SCID-hu mice
by: Wen Ling, et al.
Published: (2025-06-01) -
Liv, død – evig liv
by: Tor Claussen
Published: (2019-01-01) -
Lange liv
Published: (2015-12-01) -
Coexistence of a Leaky SCID Phenotype With Hyperphenylalaninemia in an Adult Case
by: Ugur Musabak, et al.
Published: (2025-01-01)